ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 85 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $250,000 | -33.3% | 4,670 | +40.8% | 0.02% | -11.1% |
| Q4 2015 | $375,000 | -86.6% | 3,317 | -86.0% | 0.02% | -87.0% |
| Q3 2015 | $2,798,000 | +353.5% | 23,772 | +198.4% | 0.14% | +475.0% |
| Q2 2015 | $617,000 | +176.7% | 7,966 | +15.4% | 0.02% | +50.0% |
| Q4 2014 | $223,000 | -50.4% | 6,905 | -62.4% | 0.02% | -33.3% |
| Q3 2014 | $450,000 | +112.3% | 18,376 | +53.4% | 0.02% | +140.0% |
| Q2 2014 | $212,000 | +15.8% | 11,976 | +9.7% | 0.01% | -28.6% |
| Q4 2013 | $183,000 | – | 10,918 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |